2014
|
Invention
|
Abuse resistant forms of immediate release oxymorphone, method of use and method of making. An ab... |
|
Invention
|
Abuse resistant forms of extended release hydrocodone, method of use and method of making. An abu... |
|
Invention
|
Abuse resistant forms of immediate release hydrocodone, method of use and method of making.
An a... |
|
Invention
|
Abuse resistant forms of immediate release hydromorphone, method of use and method of making. An ... |
|
Invention
|
Abuse resistant forms of extended release hydromorphone, method of use and method of making.
An ... |
|
Invention
|
Abuse resistant forms of extended release oxymorphone, method of use and method of making. An abu... |
|
Invention
|
Pharmaceutical compositions comprising a ph-dependent component and ph-raising agent. An oral pha... |
|
Invention
|
Orally administrable compositions and methods of deterring abuse by intranasal administration. Or... |
|
Invention
|
Abuse deterrent compositions and methods of use.
Orally administrable pharmaceutical composition... |
|
Invention
|
Abuse resistant forms of extended release morphine, method of use and method of making. An abuse ... |
|
Invention
|
Abuse deterrent compositions and methods of use. Orally administrable pharmaceutical compositions... |
2012
|
Invention
|
Abuse resistant oral opioid formulations. An abuse resistant oral pharmaceutical composition, com... |
|
Invention
|
Abuse resistant forms of immediate release oxycodone, method of use and method of making. An abus... |
2011
|
Invention
|
Abuse resistant drugs, method of use and method of making. An abuse resistant oral pharmaceutical... |
|
Invention
|
Abuse resistant forms of extended release morphine with oxycodone, method of use and method of ma... |
|
Invention
|
Abuse resistant forms of extended release hydromorphone, method of use and method of making. An a... |
2009
|
Invention
|
Pharmaceutical compositions configured to deter dosage form splitting. An oral pharmaceutical com... |
|
Invention
|
Pharmaceutical compositions configured to deter dosage form splitting. An oral pharmaceutic... |